Evidence map›Paper›PMID 40289811›Full record

ArticleCirculation2025

Splenic CD169

Mohamed Ameen Ismahil, Guihua Zhou, Shreya Rajasekar, Min Gao, Shyam S Bansal, Bindiya Patel, Nita Limdi, Min Xie, Sergey Antipenko, Gregg Rokosh and 2 more

Abstract read
In one paragraph

Article in Circulation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Macrophages and the Survival of Cardiomyocytes After Myocardial Infarction.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. TIM-4International journal of biological sciences · 2026
    Article
  10. Article
  11. Review
  12. Bone marrow-derived CD169Experimental & molecular medicine · 2025
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Mohamed Ameen IsmahilDivision of Cardiology, Department of Medicine, Washington University in St Louis, MO (M.A.I., S.R., G.R., T.H., S.D.P.).ORCID 0000-0002-7452-6123
Guihua ZhouDepartments of Medicine, Cardiovascular Disease (M.A.I., G.Z., M.G., S.S.B., B.P., M.X., S.A., G.R., T.H., S.D.P.), University of Alabama at Birmingham. Dr Bansal is currently affiliated with the Heart and Vascular Institute, Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.
Shreya RajasekarDivision of Cardiology, Department of Medicine, Washington University in St Louis, MO (M.A.I., S.R., G.R., T.H., S.D.P.).
Min GaoDepartments of Medicine, Cardiovascular Disease (M.A.I., G.Z., M.G., S.S.B., B.P., M.X., S.A., G.R., T.H., S.D.P.), University of Alabama at Birmingham. Dr Bansal is currently affiliated with the Heart and Vascular Institute, Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.
Shyam S BansalDepartments of Medicine, Cardiovascular Disease (M.A.I., G.Z., M.G., S.S.B., B.P., M.X., S.A., G.R., T.H., S.D.P.), University of Alabama at Birmingham. Dr Bansal is currently affiliated with the Heart and Vascular Institute, Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.ORCID 0000-0001-9179-6478
Bindiya PatelDepartments of Medicine, Cardiovascular Disease (M.A.I., G.Z., M.G., S.S.B., B.P., M.X., S.A., G.R., T.H., S.D.P.), University of Alabama at Birmingham. Dr Bansal is currently affiliated with the Heart and Vascular Institute, Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.
Nita LimdiNeurology (N.L.), University of Alabama at Birmingham. Dr Bansal is currently affiliated with the Heart and Vascular Institute, Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.
Min XieDepartments of Medicine, Cardiovascular Disease (M.A.I., G.Z., M.G., S.S.B., B.P., M.X., S.A., G.R., T.H., S.D.P.), University of Alabama at Birmingham. Dr Bansal is currently affiliated with the Heart and Vascular Institute, Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.ORCID 0000-0002-2967-3490
Sergey AntipenkoDepartments of Medicine, Cardiovascular Disease (M.A.I., G.Z., M.G., S.S.B., B.P., M.X., S.A., G.R., T.H., S.D.P.), University of Alabama at Birmingham. Dr Bansal is currently affiliated with the Heart and Vascular Institute, Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.ORCID 0000-0002-5079-6735
Gregg RokoshDivision of Cardiology, Department of Medicine, Washington University in St Louis, MO (M.A.I., S.R., G.R., T.H., S.D.P.).
Tariq HamidDivision of Cardiology, Department of Medicine, Washington University in St Louis, MO (M.A.I., S.R., G.R., T.H., S.D.P.).
Sumanth D PrabhuDivision of Cardiology, Department of Medicine, Washington University in St Louis, MO (M.A.I., S.R., G.R., T.H., S.D.P.).ORCID 0000-0002-7247-7241

Funding

Macrophage Circadian Clock Disruption and Inflammation in Heart FailureR01HL147549 · NHLBI · WASHINGTON UNIVERSITY · PI PRABHU, SUMANTH D, YOUNG, MARTIN E · 2019 to 2022
$2.3M
Cardiac Macrophages as Disease Drivers in Chronic Ischemic Heart FailureR01HL157999 · NHLBI · WASHINGTON UNIVERSITY · PI PRABHU, SUMANTH D · 2021 to 2024
$2.1M
Cardiac Mesenchymal Stem Cells and Myocardial Fibrosis: Role of Platelet Derived Growth Factor Receptor SignalingR01HL137046 · NHLBI · WASHINGTON UNIVERSITY · PI HAMID, TARIQ · 2018 to 2021
$1.5M
Splenic Marginal Zone Macrophages in Chronic Ischemic Heart FailureR01HL125735 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PRABHU, SUMANTH D · 2015 to 2018
$1.5M
Patient Oriented Research in Personalized Antithrombotic TherapyK24HL133373 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIMDI, NITA A · 2016 to 2025
$1.2M
Beta-hydroxybutyrate Protects Mitochondria During Cardiac Ischemia Reperfusion InjuryR03HL141620 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI XIE, MIN · 2018 to 2019
$149k
BLRD VA I01 BX002706NHLBI NIH HHS K24 HL133373NHLBI NIH HHS R01 HL125735NHLBI NIH HHS R01 HL137046NHLBI NIH HHS R01 HL147549NHLBI NIH HHS R01 HL157999NHLBI NIH HHS R03 HL141620
6 · The paper itself

Abstract

backgroundFidelity of wound healing after myocardial infarction (MI) is an important determinant of subsequent adverse cardiac remodeling and failure. Macrophages derived from infiltrating Ly6C

methodsWe used a variety of in vivo murine models and orthogonal approaches, including surgical MI, flow cytometry and single-cell RNA sequencing, lineage tracing and cell tracking, splenectomy, parabiosis, cell adoptive transfer, and functional characterization, to establish an essential role for splenic CD169

resultsSplenic CD169

conclusionsSplenic CD169

Indexed as

MacrophagesMyocardial InfarctionSialic Acid Binding Ig-like Lectin 1SpleenWound HealingAnimalsDisease Models, AnimalFemaleHumansMaleMembrane ProteinsMiceMice, Inbred C57BLMonocytesMembrane ProteinsSialic Acid Binding Ig-like Lectin 1Siglec1 protein, mouseTIM-4 protein, mouseheart failureinflammationmacrophagesmyocardial infarctionspleen

Identifiers

PMID40289811
PMCPMC12165546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.